Patents
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
03/2005
03/10/2005US20050054536 Reacting an cyanoacrylate compound with amidine compound
03/10/2005US20050053678 Methods and compositions for betel nut chewing gum
03/09/2005EP1512397A1 O-substituted hydroxyaryl derivatives
03/09/2005EP1511472A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/09/2005CN1592618A Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
03/09/2005CN1590384A Process for producing a pyran compound
03/09/2005CN1590372A Arylphenyl-substituted cyclic ketoenols
03/09/2005CN1192045C Synthesis of copolymers containing anhydrofructose derivatives
03/08/2005US6864397 E.g., 1-(4-(4-pentylcyclohexyl)cyclohexyldifluoromethoxy)-4 -trifluoromethoxybenzene; preparation from difluorocyclo-hexylidenes, e.g. 1-(4-(trans-4-propylcyclohexyl)cyclohexyl-difluoromethoxy)-3,4,5 -trifluorobenzene; liquid crystals
03/08/2005US6864278 Antifungal agents of sordarin derivatives
03/03/2005WO2005019159A1 OPTICALLY ACTIVE α-AMINOOXYKETONE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF
03/03/2005WO2004101508A3 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
03/03/2005US20050049429 Kinase inhibitors; antiproliferative agents; anticancer agents; psoriasis; restenosis
03/03/2005US20050049422 New salts of HMG-CoA reductase inhibitors
03/03/2005US20050049414 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
03/03/2005US20050049283 Compounds that inhibit factor xa activity
03/03/2005US20050049280 e.g., ethyl 4-(hydroxyaminocarbonyl)-4-[4-(p-trifluoromethylphenoxy)piperidin-1-ylsulfonyl]piperidine-N-carboxylate
03/03/2005US20050049249 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors
03/03/2005US20050048315 Such as 4-(dicyanomethylene)-2-{p-(dialkylamino)styryl}-6-{p-(diarylamino)styryl}-4H-pyran; improved carrier transportation and exhibits long wavelength light
03/03/2005DE102004021338A1 New pyran compounds are useful as components in liquid crystalline media, preferably in optoelectronic displays
03/02/2005EP1510515A1 Phenylglycine derivatives as serine protease inhibitors
03/02/2005EP1509495A1 Anilino liver x-receptor modulators
02/2005
02/24/2005WO2005016277A2 Arylsulfonamidobenzylic compounds
02/24/2005US20050043399 Dimeric compounds and their use as anti-viral agents
02/24/2005US20050043278 administering to a patient a hydroxy compound to treat aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, septicemia and syndrome X
02/24/2005CA2533638A1 Arylsulfonamidobenzylic compounds
02/23/2005EP1508560A2 Substituted Phenylketoenols
02/23/2005EP1507504A1 Cycloalkyl inhibitors of potassium channel function
02/23/2005CN1585767A Dimeric compounds and their use as anti-viral agents
02/23/2005CN1585766A Dimeric compounds and their use as anti-viral agents
02/23/2005CN1585765A Dimeric compounds and their use as anti-viral agents
02/23/2005CN1585764A Dimeric compounds and their use as anti-viral agents
02/23/2005CN1585746A Beta-amyloid protein production/secretion inhibitors
02/23/2005CN1583737A Synthesis of cinvastatin
02/23/2005CN1583736A Extraction and refinement of lovastatin
02/22/2005US6858749 Process for enantioselectively producing the (R)-delta-lactone
02/22/2005US6858741 Use as pesticides and herbicides
02/22/2005US6858724 Used as anti-tumor agents and/or anti-HIV agents having immunostimulate activities; inversion of OR2 to OR1 in glucopyranose derivtives (R1= H or acetyl, R2= a leaving group such as tosylate, trifluoromesylate or methanesulfonate
02/22/2005US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors
02/17/2005WO2005014563A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors
02/17/2005WO2004067489A8 Hydroxyl compounds and compositions for cholesterol management and related uses
02/17/2005US20050038267 Pyran derivatives containing an exocyclic double bond
02/17/2005US20050038112 prevention, control and treatment of cancer; leukemia
02/17/2005US20050038108 4S, 5R, 6R)-5-Acetylamino-4-azido-6-[(S)-4-nitrophenoxycarbonyloxy)-(2-oxo-[1,3]dioxolan-4R-yl)methyl]- 5,6-dihydro-4H-pyran2-carboxylic acid methylester; modified at the carboxyl or hydroxyl or amino functions; orthomyxovirus and paramyxovirus infections; a long lung residency time and high potency
02/17/2005US20050038106 polyketides; for inhibiting proliferation of lung cancer or leukemia cells
02/17/2005US20050038021 2,4,5,-trisubstituted phenylketo-enols for use as pesticides and herbicides
02/17/2005US20050037289 monomers that can be homopolymerized or copolymerized with other reactive components to make resins within sub-200 nanometer (nm) photoresist compositions
02/17/2005DE102004022891A1 Novel pyran compounds having exocyclic double bonds are useful as components in liquid crystalline media, preferably in optoelectronic displays
02/17/2005CA2534675A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors
02/16/2005EP1506211A1 C-aryl glucoside sglt2 inhibitors and method
02/16/2005EP1506183A1 Method of forming iron hydroxypyrone compounds
02/16/2005EP1506158A2 Diamino-functional chalcones
02/16/2005EP1506157A2 Amino-functional chalcones
02/16/2005EP1268463B1 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
02/16/2005EP1064285B1 Novel cephalotaxane derivatives and process for their preparation
02/16/2005EP0986540B1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers
02/15/2005US6855832 O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
02/14/2005WO2005024025A1 Polyene polyketides and methods of production
02/10/2005WO2005012279A1 Lactonization process
02/10/2005WO2005012246A1 Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin
02/10/2005WO2005012228A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity
02/10/2005WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor
02/10/2005US20050032883 Novel substance fki-1083 and process for producing the same
02/10/2005US20050032853 Intermediates for preparing neuraminidase inhibitor conjugates
02/10/2005US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases
02/10/2005US20050032772 Compounds useful as reversible inhibitors of cysteine proteases
02/10/2005US20050032176 Modular polyketide synthases with altered activity
02/09/2005EP1505050A1 Bridged carbocyclic compounds and methods of making and using same
02/09/2005EP1124443B1 Solid delivery systems for aroma ingredients
02/09/2005CN1578769A Processes for the manufacturing of 3-hydroxy-n, 1, 6-trialkyl-4-oxo-1, 4-dihydropyridine-2-carboxamide
02/08/2005US6852717 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor; for use in therapy of diseases and pathological conditions involving inflammation such as chronic inflammatory disease
02/08/2005US6852711 HIV protease inhibitors
02/03/2005WO2005009983A1 Method for the detection of nucleophilic chemical species
02/03/2005WO2005009940A1 Novel aminobenzophenone compounds
02/03/2005CA2530302A1 Novel aminobenzophenone compounds
02/02/2005EP1501844A1 Disaccharides for drug discovery
02/02/2005EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors
02/02/2005EP1501815A1 Substituted phenylacetamides and their use as glucokinase activators
02/02/2005EP1501800A1 Bombesin antagonists
02/02/2005EP1501791A1 Amino acid analogues
02/02/2005EP1501777A1 Direct, enantioselective aldol coupling of aldehydes using chiral organic catalysts
02/01/2005US6849744 3-(substituted phenyl),4-substituted-5H-1,2-oxathiole 2-oxide or 2,2-dioxide compounds useful as agricultural fungicides, insecticides, herbicides
02/01/2005US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N
02/01/2005CA2276719C Anilide derivatives and antiarrhythmic agents containing the same
01/2005
01/27/2005US20050020588 Cysteine protease inhibitors
01/27/2005US20050019278 Block solar radiation; applying to skin, hair
01/27/2005US20050017216 Liquid crystals; using metastasis catalysts; reduction, hydrogenation
01/26/2005EP1500643A1 Benzamide derivatives
01/26/2005EP1499573A1 Homogeneous process for the hydrogenation of carboxylic acids and derivatives thereof
01/26/2005EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
01/26/2005CN1186335C Process for obtaining HMG-CoA reductase inhibitors of high purity
01/20/2005WO2005005432A1 Novel 2,7-dioxo-bicyclo[4.3.0]non-5-yl-urea derivatives
01/20/2005WO2005005406A1 Process for production of 4-aminotetrahydropyrans and salts thereof with acids, intermediates for the process, and process for production thereof
01/20/2005WO2005004810A2 Arylsulfonamide derivatives
01/20/2005WO2004089926A8 Genipin derivatives and uses thereof
01/19/2005EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
01/19/2005EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
01/19/2005EP0777492B1 Combinatorial libraries of substrate-bound cyclic organic compounds
01/19/2005CN1568370A Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
01/19/2005CN1185224C Oxidation of ketones to esters using tin substituted zeolite beta
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 129